SARS Spike (306-515)

Coronavirus Spike Receptor Binding Domain (306-515 a.a.), Recombinant
Shipped with Ice Packs
In Stock

Description

Definition and Biological Context

SARS Spike (306-515) refers to a recombinant protein fragment derived from the receptor-binding domain (RBD) of the SARS-CoV-1 spike glycoprotein. This region spans amino acids 306–515 (or 306–527 in some studies ) within the S1 subunit, which mediates viral entry by binding to the angiotensin-converting enzyme 2 (ACE2) receptor on host cells . The RBD is critical for both viral infectivity and immune recognition, making it a focal point for therapeutic and vaccine development .

Functional Role in Viral Entry

  • ACE2 Binding: Residues 424–494 in the RBM form hydrogen bonds and hydrophobic interactions with ACE2 .

  • Conformational Flexibility: The RBD transitions between "up" (ACE2-accessible) and "down" (closed) states, influenced by mutations like D614G .

  • Membrane Fusion: Post-receptor binding, the S1 subunit dissociates, allowing the S2 subunit to mediate viral-host membrane fusion .

Key Mutations and Variant Impacts

Emergent SARS-CoV-2 variants often accumulate mutations in the RBD, altering ACE2 affinity or immune evasion:

Table 2: Notable Mutations Within/Proximal to 306-515

VariantMutationImpact on RBD Function
Alpha (B.1.1.7)N501Y↑ ACE2 binding affinity; enhanced transmissibility
Beta (B.1.351)K417N/E484KImmune escape from neutralizing antibodies
Omicron (BA.1)G446S/G496SReduced antibody neutralization; altered conformational dynamics

Production and Biophysical Properties

  • Expression: Optimized in HEK293 cells for proper glycosylation and folding .

  • Purity: >90% as confirmed by SDS-PAGE .

  • Formulation: Lyophilized in PBS with 5% trehalose to prevent aggregation .

Immunogenicity and Therapeutic Applications

  • Vaccine Development: RBD-based vaccines (e.g., RBD-Fc fusion proteins) induce potent neutralizing antibodies in preclinical models .

  • Monoclonal Antibodies: Antibodies targeting the RBD (e.g., S309, CR3022) block ACE2 binding or destabilize the spike trimer .

  • Diagnostics: Used in ELISA and flow cytometry to quantify neutralizing antibodies in sera .

Research Findings and Clinical Relevance

  • Antibody Neutralization: RBD-specific antibodies achieve IC50 values as low as 1:10,240 in pseudovirus assays .

  • Cross-Reactivity: The RBD retains partial conservation across coronaviruses, enabling broad-spectrum antibody design .

  • Stabilization Strategies: Proline substitutions (e.g., S-2P) improve RBD stability and immunogenicity .

Challenges and Future Directions

  • Variant Evolution: Mutations like E484K and N501Y necessitate continuous updates to vaccines/therapeutics .

  • Structural Heterogeneity: Differences between recombinant RBD (306-515) and full-length spike may limit functional studies .

Product Specs

Introduction

The SARS Coronavirus possesses an envelope with three key structural proteins: membrane (M), envelope (E), and spike (S) proteins. The spike (S) glycoprotein plays a crucial role in viral infection by binding to a cellular receptor, facilitating membrane fusion, and enabling the virus to enter susceptible cells. This critical function makes the S-protein a primary target for neutralizing antibodies.

Description

This recombinant SARS Spike protein consists of 220 amino acids (spanning positions 306 to 515) and has a molecular weight of 24.8 kDa. A 6 amino acid His-tag is fused to the C-terminus to facilitate purification, which is achieved using proprietary chromatographic methods.

Physical Appearance
The product is a sterile, filtered solution that appears colorless.
Formulation

The SARS Spike (306-515) solution is provided at a concentration of 0.5mg/ml and is formulated in Phosphate-Buffered Saline (pH 7.4) with 10% Glycerol.

Stability

For optimal storage, the product should be kept at 4°C if it will be used within 2-4 weeks. For longer-term storage, it is recommended to freeze the product at -20°C. To further enhance stability during long-term storage, consider adding a carrier protein (0.1% HSA or BSA). Repeated freezing and thawing should be avoided.

Purity

The purity of the SARS Spike protein is greater than 95.0%, as determined by SDS-PAGE analysis.

Biological Activity

The biological activity of the SARS Spike protein is assessed by its binding affinity to Human ACE-2 in a functional ELISA (using CAT# enz-1159).

Synonyms

Spike glycoprotein, S glycoprotein, Peplomer protein, E2 glycoprotein precursor, Severe acute repiratory Syndrome-related Coronavirus, SARS, SRAS-CoV, SARS-CoV1, E2.

Source

HEK293 Cells.

Amino Acid Sequence

DGSMRVVPSG DVVRFPNITN LCPFGEVFNA TKFPSVYAWE RKKISNCVAD YSVLYNSTFF STFKCYGVSA TKLNDLCFSN VYADSFVVKG DDVRQIAPGQ TGVIADYNYK LPDDFMGCVL AWNTRNIDAT STGNYNYKYR YLRHGKLRPF ERDISNVPFS PDGKPCTPPA LNCYWPLNDY GFYTTTGIGY QPYRVVVLSF ELLNAPATVC GPKLHHHHHH

Q&A

What is the SARS Spike (306-515) region and what is its functional significance?

The SARS Spike (306-515) region encompasses a critical portion of the receptor-binding domain (RBD), which spans approximately positions 319-541 in the spike glycoprotein. This region is directly involved in host-pathogen interactions, specifically binding to the angiotensin-converting enzyme 2 (ACE2) receptor on host cells. The significance of this region lies in its:

  • Direct role in initiating viral entry through receptor recognition

  • Function as a primary target for neutralizing antibodies

  • Importance in determining host range and tissue tropism

  • Critical role in vaccine development and therapeutic strategies

Structurally, this region forms part of the globular head domain of the spike protein, which undergoes conformational changes during receptor binding. Mutations in this region can significantly alter viral infectivity and immune evasion capabilities, as seen with various SARS-CoV-2 variants .

How does glycosylation affect the structure and function of the SARS Spike (306-515) region?

Glycosylation plays multiple crucial roles in the structure and function of the SARS Spike (306-515) region:

  • Immune Evasion: The glycan shield provides protection against antibody recognition, effectively masking potential neutralizing epitopes. Native viral spike proteins are more heavily glycosylated than recombinant versions, potentially affecting immunogenicity studies .

  • Structural Stability: N-linked glycans contribute to protein folding, stability, and solubility. The removal of glycosylation sites can lead to structural perturbations that affect protein functionality.

  • Receptor Interaction: While glycans within the RBD don't directly contact ACE2, they influence the conformational dynamics that govern receptor binding.

  • Methodological Considerations: Glycosylation heterogeneity presents challenges for structural studies, often requiring specialized approaches for accurate characterization. Cryo-EM studies reveal that viral S proteins show more extensive glycosylation than recombinant versions .

Research has demonstrated that the glycosylation pattern varies between in vitro expressed recombinant protein and native viral spike, which may have implications for structural analysis and vaccine development .

What role does the SARS Spike (306-515) region play in viral evolution and variant emergence?

The SARS Spike (306-515) region represents a critical evolutionary hotspot in the viral genome, balancing selective pressures between immune evasion and receptor binding functionality:

  • Mutational Landscape: This region exhibits significant variability across SARS-CoV-2 variants. Key mutations like N501Y have been associated with increased transmission through enhanced ACE2 binding .

  • Evolutionary Constraints: Despite variability, certain residues remain highly conserved due to their essential structural roles. Mutations in the RBD must maintain proper protein folding while potentially altering surface properties.

  • Variant Emergence: Multiple mutations in this region characterize variants of concern. For example, the alpha (B.1.1.7) variant contains N501Y, while the beta (B.1.351) variant contains K417N, E484K, and N501Y mutations that affect both transmission and antigenicity .

  • Selective Pressure: The dual pressures of immune escape and receptor binding optimization drive the evolution of this region, leading to "mutation constellations" rather than isolated substitutions.

Comprehensive mutational analysis reveals that single amino acid substitutions can dramatically alter protein conformation, affecting cleavage site accessibility and ultimately viral transmissibility and infectivity .

What are the optimal techniques for expressing and purifying the SARS Spike (306-515) region for structural studies?

Expression and purification of the SARS Spike (306-515) region requires careful optimization to maintain native conformation and functionality:

Expression SystemAdvantagesDisadvantagesTypical YieldGlycosylation Profile
HEK293 CellsNear-native glycosylation, proper foldingSlower growth, more expensive5-15 mg/LComplex, heterogeneous
Insect Cells (Sf9, Hi5)High yield, proper foldingSimplified glycosylation10-30 mg/LHigh-mannose, paucimannose
E. coliHighest yield, economicalLacks glycosylation, refolding often required50-200 mg/LNone
Yeast (P. pastoris)High yield, some glycosylationHyperglycosylation20-80 mg/LHigh-mannose, heterogeneous

For optimal results in structural studies, a mammalian expression system is generally recommended due to proper post-translational modifications. Key considerations include:

  • Construct Design: Including stabilizing mutations (like disulfide bond introduction) can enhance expression and stability.

  • Purification Strategy: A typical workflow involves affinity chromatography (Ni-NTA or Streptavidin), followed by ion exchange and size exclusion chromatography.

  • Quality Control: Monodispersity assessment via dynamic light scattering and functional validation through binding assays are essential before structural studies.

  • Storage Conditions: Purified protein stability is maximized at concentrations of 2-5 mg/mL in phosphate or HEPES buffer with 150 mM NaCl at pH 7.4.

For cryo-EM studies specifically, the addition of 0.01-0.05% detergent like LMNG can prevent protein aggregation at the air-water interface during grid preparation .

What strategies are most effective for analyzing conformational changes in the SARS Spike (306-515) region?

Analyzing conformational changes in the SARS Spike (306-515) region requires multi-faceted approaches:

A significant finding from cryo-electron tomography studies reveals that the spike protein contains three distinct hinges in its stalk domain, providing unexpected orientational freedom that allows the spike head to scan the host cell surface while remaining protected by its glycan shield .

How should researchers approach epitope mapping for antibodies targeting the SARS Spike (306-515) region?

Comprehensive epitope mapping for antibodies targeting the SARS Spike (306-515) region requires integrated approaches:

  • Structural Methods:

    • X-ray Crystallography: Provides atomic-resolution details of antibody-antigen interfaces

    • Cryo-EM: Particularly valuable for conformational epitopes and flexible regions

    • NMR Spectroscopy: Offers dynamics information alongside structural data

  • Biochemical and Biophysical Approaches:

    • Hydrogen-Deuterium Exchange MS: Maps regions with altered solvent accessibility upon antibody binding

    • Cross-linking Mass Spectrometry: Identifies residues in close proximity at binding interfaces

    • SPR/BLI Competition Assays: Determines if antibodies compete for overlapping epitopes

  • Mutational Analysis:

    • Alanine Scanning: Systematic mutation of residues to alanine identifies critical binding residues

    • Deep Mutational Scanning: Comprehensive analysis of thousands of mutations simultaneously

    • Escape Mutant Selection: Identifies mutations that abrogate antibody binding under selective pressure

  • Computational Approaches:

    • Epitope Prediction Algorithms: Machine learning models predict potential antibody binding sites

    • Molecular Docking: In silico modeling of antibody-antigen complexes

    • Molecular Dynamics: Simulates dynamics of antibody-antigen interactions

Research has shown that the conformational flexibility of the spike protein, facilitated by the three hinges in the stalk domain, may affect epitope accessibility and antibody binding kinetics in ways not captured by static structural models. This has implications for designing broadly neutralizing antibodies that must recognize the RBD across multiple conformational states .

How do specific mutations in the SARS Spike (306-515) region affect ACE2 binding affinity and neutralizing antibody escape?

The relationships between mutations, binding affinity, and antibody escape are complex and often interdependent:

MutationEffect on ACE2 BindingAntibody Escape MechanismStructural Consequence
N501Y↑ Binding affinity (~6-10 fold)Moderate escape from some mAbsEnhanced hydrophobic interactions with Y41 of ACE2
E484KMinimal change/slight ↑Strong escape from multiple mAbsCharge reversal disrupts antibody recognition
K417N/T↓ Binding affinityEscape from specific mAb classesDisrupts salt bridge with D30 of ACE2
L452R↑ Binding affinityModerate escape from multiple mAbsIncreases hydrophobic interactions, reduces RBD flexibility
D614GIndirect ↑ via conformational changeLimited direct effectIncreases RBD "up" state probability

The D614G mutation, which is outside the RBD itself, has become dominant worldwide and appears to enhance viral fitness through conformational effects that indirectly increase ACE2 binding . This mutation alters the equilibrium between "up" and "down" RBD conformations, increasing the probability of ACE2 engagement.

Mutations often exhibit epistatic effects, where their impact depends on the presence of other mutations. The combination of K417N, E484K, and N501Y in the Beta variant creates a binding profile distinct from any single mutation, with complex effects on both ACE2 binding and antibody recognition.

Computational molecular dynamics simulations have revealed that mutations can also affect the structural dynamics of the RBD, altering its conformational flexibility and thereby modifying both binding kinetics and thermodynamic stability .

What are the implications of the stalk domain flexibility for SARS spike protein function and therapeutic targeting?

The discovery of three hinge regions (hip, knee, and ankle) in the stalk domain of the SARS spike protein has significant implications for understanding viral function and developing therapeutics:

  • Functional Implications:

    • Enhanced Cell Surface Scanning: The flexible hinges allow the spike head to "scan" the host cell surface while remaining protected by the glycan shield

    • Immune Evasion: Conformational flexibility complicates antibody recognition by presenting a moving target

    • Fusion Mechanics: Hinge mobility likely facilitates the dramatic conformational changes required during membrane fusion

  • Therapeutic Targeting Strategies:

    • Hinge-Specific Antibodies: Developing antibodies that recognize hinge regions could potentially "lock" the spike in non-functional conformations

    • Small Molecule Inhibitors: Compounds that bind at hinge interfaces could reduce flexibility required for function

    • Structure-Based Design Considerations: Therapies must account for the dynamic nature of the spike rather than relying solely on static structural models

  • Methodology Implications:

    • In Situ Studies: Native context studies are crucial as flexibility may be constrained in recombinant systems

    • Dynamic Simulations: Computational models must incorporate full range of motion observed in cryo-ET studies

    • Ensemble Approaches: Therapeutic screening should test against multiple conformational states

This unexpected flexibility explains how the spike can effectively engage with host receptors despite the dense packing of spikes on the viral surface and provides new targets for therapeutic intervention beyond the traditional focus on the RBD itself .

How do the differences between recombinant and native SARS Spike (306-515) affect structural and functional studies?

Significant differences exist between recombinant and native SARS spike proteins that impact research interpretations:

  • Conformational Distribution:

    • Native Spike: Predominantly exists in the closed prefusion conformation on virion surfaces

    • Recombinant Spike: Shows higher proportions of the "open" RBD conformation

    • Research Impact: Binding studies with recombinant proteins may overestimate receptor accessibility

  • Glycosylation Patterns:

    • Native Spike: More extensively glycosylated with complex glycan structures

    • Recombinant Spike: Glycosylation depends on expression system, often less complex

    • Research Impact: Immunogenicity, stability, and binding properties may differ significantly

  • Stalk Domain Properties:

    • Native Spike: Exhibits three-hinge flexibility in its natural membrane context

    • Recombinant Spike: Often studied with truncated or stabilized stalks

    • Research Impact: Dynamics critical for function may be missed in recombinant systems

  • Proteolytic Processing:

    • Native Spike: Processing patterns vary with host cells and culture conditions

    • Recombinant Spike: Often engineered with modifications at cleavage sites

    • Research Impact: Fusion activation mechanisms may differ

  • Membrane Environment:

    • Native Spike: Embedded in viral envelope with specific lipid composition

    • Recombinant Spike: Often studied in detergent micelles or artificial membranes

    • Research Impact: Membrane interactions that influence conformation are altered

Cryo-electron tomography studies reveal that native spike proteins on intact virions show distinct structural properties compared to purified recombinant proteins, suggesting caution when extrapolating findings between systems. For the most accurate understanding, complementary approaches using both native and recombinant proteins are recommended .

How can researchers reconcile contradictory findings in SARS Spike (306-515) structural studies?

Contradictory findings in structural studies of the SARS Spike (306-515) region require systematic reconciliation approaches:

  • Methodological Differences Analysis:

    • Resolution Disparities: Different methods provide varying levels of detail (X-ray: atomic; Cryo-EM: near-atomic; SAXS: low resolution)

    • Sample Preparation Variations: Detergents, pH, ionic strength affect observed conformations

    • Construct Design Differences: Tag positions, truncation boundaries, stabilizing mutations

  • Biological Context Considerations:

    • Native vs. Recombinant: Contradictions often arise between virion-associated and recombinant protein studies

    • Host Cell Variations: Different expression systems result in distinct post-translational modifications

    • Strain-Specific Features: Sequence variations between isolates can explain structural differences

  • Conformational Ensemble Recognition:

    • Dynamic Nature: Proteins exist as conformational ensembles rather than single states

    • State Selection: Different experimental conditions may select specific conformational subsets

    • Energy Landscape: Contradictory structures may represent different minima on a complex energy surface

  • Reconciliation Approaches:

    • Integrative Structural Biology: Combining multiple techniques (Cryo-EM, crystallography, SAXS, HDX-MS)

    • Computational Validation: Molecular dynamics simulations to test structural model plausibility

    • Critical Assessment: Systematic evaluation of methodological limitations for each finding

Recent studies have demonstrated that what initially appeared as contradictions between native and recombinant spike structures actually revealed important biological features - the conformational flexibility enabled by the three hinges in the stalk domain is a key example of how apparent contradictions led to deeper understanding .

What computational methods are most effective for predicting the impact of mutations in the SARS Spike (306-515) region?

Computational prediction of mutation impacts requires sophisticated methods addressing multiple aspects of protein function:

  • Structure-Based Energy Calculations:

    • FoldX and Rosetta: Calculate ΔΔG of folding to predict stability changes

    • Molecular Mechanics/Poisson-Boltzmann Surface Area (MM/PBSA): Estimates binding free energy changes

    • Application: Effective for mutations at well-defined interfaces but less reliable for allosteric effects

  • Molecular Dynamics Approaches:

    • Equilibrium Simulations: Reveal subtle conformational changes induced by mutations

    • Accelerated Sampling: Techniques like metadynamics explore conformational landscape shifts

    • Application: Captures dynamic effects beyond static structures but computationally intensive

  • Machine Learning Methods:

    • Sequence-Based Predictors: Use evolutionary information to predict tolerance to mutations

    • Structure-Based Neural Networks: Integrate 3D context into predictions

    • Application: Rapidly screens many mutations but accuracy depends on training data quality

  • Network Analysis:

    • Residue Interaction Networks: Identifies communication pathways disrupted by mutations

    • Dynamical Network Analysis: Maps allosteric effects of mutations on protein motion

    • Application: Particularly valuable for mutations distant from functional sites

  • Integrative Approaches:

    • Multi-feature Models: Combine sequence conservation, structure, and dynamics information

    • Ensemble-Based Methods: Account for protein conformational heterogeneity

    • Application: Most accurate but requires extensive computational resources

Validation against experimental data is essential, as computational methods vary in accuracy depending on the mutation location and type. The most effective approach combines multiple computational methods with targeted experimental validation, especially for mutations in regions with documented flexibility like the RBD .

How should researchers interpret glycosylation heterogeneity in structural studies of the SARS Spike (306-515) region?

Glycosylation heterogeneity presents unique challenges for structural interpretation:

  • Structural Representation Approaches:

    • Composite Modeling: Integrating glycan electron density from multiple structures

    • Ensemble Representation: Depicting multiple potential glycan conformations

    • Minimal Representation: Showing only the core glycan structure with high occupancy

  • Impact on Experimental Data Interpretation:

    • Cryo-EM Density Analysis: Distinguishing between protein and glycan contributions to weak density

    • X-ray Crystallography: Accounting for glycan-mediated crystal contacts

    • Mass Spectrometry: Quantifying site-specific glycoform distributions

  • Biological Relevance Assessment:

    • Conservation Analysis: Evaluating glycosite conservation across strains and variants

    • Accessibility Mapping: Correlating glycan positions with surface exposure

    • Functional Impact: Relating glycosylation patterns to receptor binding and antibody recognition

  • Methodological Considerations:

    • Expression System Influence: Acknowledging glycosylation differences between systems

    • In Vitro vs. In Vivo: Recognizing that tissue culture-derived viruses may show altered glycosylation

    • Native Context: Considering how membrane environment affects glycan presentation

Research has shown that native viral spikes display more extensive glycosylation than recombinant proteins, with implications for immune recognition and structural interpretation. This heterogeneity should be viewed not as experimental noise but as a functionally relevant feature of the spike protein that contributes to immune evasion while maintaining receptor binding function .

What emerging technologies show promise for advancing SARS Spike (306-515) research?

Several cutting-edge technologies are poised to transform SARS Spike research:

  • Time-Resolved Cryo-Electron Microscopy:

    • Microfluidic Mixing Devices: Capture structural intermediates during receptor binding

    • Time-Resolved Sample Vitrification: Freeze reactions at defined timepoints

    • Potential Impact: Visualization of transient conformational states during receptor engagement

  • Advanced Computational Methods:

    • AI-Driven Structure Prediction: Tools like AlphaFold2 for modeling spike variants

    • Machine Learning Classification: Improved particle sorting for heterogeneous samples

    • Quantum Mechanical Modeling: More accurate binding energy calculations for drug design

    • Potential Impact: Rapid screening of mutation effects and therapeutic candidates

  • Single-Molecule Techniques:

    • High-Speed AFM: Direct visualization of conformational dynamics

    • TIRF-Based Single-Molecule FRET: Real-time monitoring of RBD movements

    • Optical Tweezers: Measuring mechanical properties of individual spike proteins

    • Potential Impact: Direct observation of spike mechanics during receptor binding

  • In Situ Structural Biology:

    • Cryo-Electron Tomography: Enhanced resolution for studying spikes in cellular context

    • Correlative Light and Electron Microscopy: Linking function to structure

    • In-Cell NMR: Structural analysis in cellular environments

    • Potential Impact: Understanding native conformational dynamics as revealed by the discovery of three flexible hinges in the stalk domain

  • Glycomics Approaches:

    • Site-Specific Glycan Analysis: Precise mapping of glycoform distributions

    • Glycoengineering: Creation of homogeneous glycoforms for structural studies

    • Glycoproteomics: Integrated analysis of glycosylation and protein dynamics

    • Potential Impact: Detailed understanding of glycan shield structure and function

The integration of these technologies promises to provide unprecedented insights into the dynamic behavior of the spike protein in its native context, building upon recent discoveries of unexpected flexibility in the spike stalk domain .

What are the critical knowledge gaps in understanding SARS Spike (306-515) structural dynamics?

Despite significant advances, several critical knowledge gaps remain:

  • Conformational Transition Mechanisms:

    • Energy Barriers: Quantitative understanding of energy landscapes governing RBD transitions

    • Triggering Mechanisms: Molecular events that initiate conformational changes

    • Allosteric Networks: Communication pathways between domains during transitions

    • Research Need: Time-resolved structural methods combined with computation

  • Glycan Shield Dynamics:

    • Glycan Conformational Ensembles: Complete mapping of glycan arrangements in space and time

    • Glycan-Protein Interactions: Impact of glycans on protein dynamics

    • Glycan-Glycan Interactions: Potential cooperative effects between adjacent glycans

    • Research Need: Integrated glycobiology and structural biology approaches

  • Membrane-Proximal Region Behavior:

    • Stalk Domain Flexibility: Complete characterization of the recently discovered triple-hinge system

    • Membrane Interactions: How the viral envelope influences spike orientation and dynamics

    • Pre-Fusion to Post-Fusion Transition: Structural rearrangements during this critical step

    • Research Need: In situ studies of intact virions during fusion

  • Variant-Specific Structural Effects:

    • Epistatic Interactions: How multiple mutations combine to affect structure and function

    • Transmissibility Mechanisms: Structural basis for enhanced transmission of variants

    • Immune Evasion Strategies: Comprehensive mapping of escape mutation mechanisms

    • Research Need: Comparative structural biology across variants with functional correlations

  • Host-Specific Adaptations:

    • Receptor Recognition Plasticity: Structural basis for cross-species transmission

    • Host Selection Pressures: How different hosts shape spike evolution

    • Adaptation Mechanisms: Structural changes during host adaptation

    • Research Need: Structural studies across host species coupled with evolutionary analysis

Addressing these gaps will require innovative approaches combining in situ structural biology, advanced computation, and functional studies to fully characterize the dynamic behavior of this critical viral protein .

Product Science Overview

Structure and Function

The spike protein is a trimeric glycoprotein composed of two subunits, S1 and S2. The S1 subunit contains the RBD, which is responsible for recognizing and binding to the host cell receptor, angiotensin-converting enzyme 2 (ACE2) in the case of SARS-CoV-2 . The binding of the RBD to ACE2 is the first step in viral entry, followed by the fusion of the viral and cellular membranes mediated by the S2 subunit.

The RBD (306-515 a.a.) is a highly conserved region among coronaviruses, making it a prime target for vaccine and therapeutic development . This domain is crucial for the virus’s ability to infect host cells and is the primary target for neutralizing antibodies generated by the immune system.

Recombinant RBD

Recombinant RBD refers to the RBD produced through recombinant DNA technology. This involves inserting the gene encoding the RBD into an expression system, such as bacteria, yeast, or mammalian cells, to produce the protein in large quantities. Recombinant RBD is used in various applications, including:

  1. Vaccine Development: The RBD is a key antigen in subunit vaccines, which aim to elicit an immune response without using live virus. These vaccines can induce the production of neutralizing antibodies that block the virus from binding to ACE2 .
  2. Diagnostic Tools: Recombinant RBD is used in serological assays to detect antibodies against SARS-CoV-2 in individuals, helping to determine past infection or immune response to vaccination .
  3. Therapeutic Research: The RBD is studied to develop monoclonal antibodies and other therapeutics that can neutralize the virus by preventing it from binding to host cells .
Importance in Research and Public Health

The study of the RBD is crucial for understanding the mechanisms of viral entry and immune evasion. Mutations in the RBD can significantly impact the virus’s transmissibility and resistance to neutralizing antibodies . For instance, the Omicron variant of SARS-CoV-2 has multiple mutations in the RBD, which reduce the efficacy of vaccines and therapeutic antibodies developed against earlier strains .

Research on recombinant RBD has led to significant advancements in the development of vaccines and therapeutics. For example, the use of recombinant RBD in vaccine formulations has shown promise in inducing broad-spectrum immunity against multiple coronavirus variants . Additionally, recombinant RBD-based diagnostics have been instrumental in tracking the spread of the virus and assessing population immunity .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2024 Thebiotek. All Rights Reserved.